Consider underlying body dysmorphic disorder in users of melanotan.
Affleck
A
A
D057215:Body Dysmorphic Disorders / Q000150:complications*; D001828:Body Image; D006801:Humans; D007279:Injections, Subcutaneous; D010456:Peptides, Cyclic / Q000009:adverse effects*; D014891:Weight Lifting / Q000523:psychology; D000521:alpha-MSH / Q000009:adverse effects / Q000031:analogs & derivatives*
D010456:Peptides, Cyclic; C079282:melanotan-II; D000521:alpha-MSH